|
|
|
Insider
Information: |
Ivers-Read Gillian C |
Relationship: |
See Remarks |
City: |
Boulder |
State: |
CO |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
293,612 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$4,404 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
293,612 |
|
|
Total
Value |
$4,404 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
27
|
Stock
price went up :
|
0
|
3
|
Stock
price went down : |
0
|
24
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-1,222.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Welltek Incorporated |
WTKND |
EVP, Development Opera... |
2008-03-07 |
0 |
2004-12-09 |
0 |
Premium* |
|
Clovis Oncology, Inc. |
CLVS |
See Remarks |
2022-11-02 |
293,612 |
2011-11-21 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
117 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
WTKND |
Welltek Incorporated |
EVP, Development Operations |
|
2007-08-24 |
4 |
S |
$38.50 |
$918,292 |
D/D |
(23,840) |
10,176 |
0 |
- |
|
WTKND |
Welltek Incorporated |
EVP, Development Operations |
|
2007-11-08 |
4 |
OE |
$1.60 |
$352,962 |
D/D |
32,813 |
42,989 |
0 |
- |
|
WTKND |
Welltek Incorporated |
EVP, Development Operations |
|
2007-12-06 |
4 |
OE |
$63.98 |
$44,786 |
D/D |
700 |
43,689 |
0 |
- |
|
WTKND |
Welltek Incorporated |
EVP, Development Operations |
|
2007-12-06 |
4 |
D |
$63.98 |
$13,884 |
D/D |
(217) |
43,472 |
0 |
- |
|
WTKND |
Welltek Incorporated |
EVP, Development Operations |
|
2008-03-07 |
4 |
D |
$0.00 |
$0 |
D/D |
(46,040) |
0 |
0 |
- |
|
WTKND |
Welltek Incorporated |
EVP, Development Operations |
|
2008-03-07 |
4 |
OE |
$72.49 |
$152,229 |
D/D |
2,100 |
46,693 |
0 |
- |
|
WTKND |
Welltek Incorporated |
EVP, Development Operations |
|
2008-03-07 |
4 |
D |
$0.00 |
$0 |
D/D |
(653) |
46,040 |
0 |
- |
|
WTKND |
Welltek Incorporated |
Executive Vice President |
|
2005-12-16 |
5 |
OE |
$1.60 |
$69,426 |
D/D |
34,016 |
34,016 |
0 |
- |
|
WTKND |
Welltek Incorporated |
officerTitle |
|
2005-12-13 |
4 |
S |
$18.37 |
$140,787 |
D/D |
(7,650) |
0 |
|
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2011-11-21 |
4 |
A |
$0.00 |
$0 |
D/D |
12,110 |
213,260 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2011-11-21 |
4 |
B |
$13.00 |
$69,199 |
D/D |
5,323 |
218,583 |
2.74 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2015-09-18 |
4 |
AS |
$112.56 |
$337,680 |
D/D |
(3,000) |
215,583 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2015-10-15 |
4 |
AS |
$91.91 |
$275,730 |
D/D |
(3,000) |
212,583 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2017-04-17 |
4 |
AS |
$56.02 |
$168,060 |
D/D |
(3,000) |
206,583 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2017-05-15 |
4 |
AS |
$47.39 |
$142,170 |
D/D |
(3,000) |
203,583 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2017-06-15 |
4 |
AS |
$61.82 |
$185,460 |
D/D |
(3,000) |
200,583 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2017-07-17 |
4 |
AS |
$91.56 |
$274,680 |
D/D |
(3,000) |
197,583 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2017-08-15 |
4 |
AS |
$70.05 |
$210,150 |
D/D |
(3,000) |
194,583 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2017-09-15 |
4 |
AS |
$69.50 |
$208,500 |
D/D |
(3,000) |
191,583 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2017-10-16 |
4 |
AS |
$84.54 |
$253,620 |
D/D |
(3,000) |
188,583 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2017-11-15 |
4 |
AS |
$63.70 |
$191,100 |
D/D |
(3,000) |
185,583 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2017-12-15 |
4 |
AS |
$64.16 |
$192,480 |
D/D |
(3,000) |
182,583 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2017-12-20 |
4 |
D |
$63.80 |
$224,066 |
D/D |
(3,512) |
186,571 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2017-12-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
190,083 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2018-01-16 |
4 |
AS |
$59.16 |
$177,480 |
D/D |
(3,000) |
183,571 |
0 |
- |
|
117 Records found
|
|
Page 1 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|